Neurology Minute

American Academy of Neurology
undefined
Jul 17, 2019 • 3min

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, pt. 2

Prof. Gil Wolfe discusses who might and might not be good candidates for thymectomy for non-thymomatous myasthenia gravis in the second part of his interview with Dr. Ted Burns. Read the full study in Lancet Neurology: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext. The study was also covered in Neurology Today, which you can read here: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2019&issue=03070&article=00004&type=FullText.
undefined
Jul 16, 2019 • 2min

The full spectrum of epilepsies from SUDEP in the North American SUDEP Registry

Dr. Orrin Devinsky summarizes his paper on the full spectrum of epilepsies and the North American SUDEP Registry. Listen to this week's full podcast for the entire interview.
undefined
Jul 15, 2019 • 2min

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Prof. Gil Wolfe summarizes his findings from his study on the long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. Read the paper in Lancet Neurology: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext. Additionally, see the Neurology Today article from March 7th featuring the study: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2019&issue=03070&article=00004&type=FullText.
undefined
Jul 12, 2019 • 2min

Neurology Residency Programs & Training

Dr. Jeffrey Ratliff discusses neurology residency programs, training, and action by the consortium of residency program directors.
undefined
Jul 11, 2019 • 3min

MuSK Myasthenia Gravis

Dr. Ted Burns discusses clinical recognition and diagnosis of MuSK myasthenia gravis.
undefined
Jul 10, 2019 • 2min

Continuum Pearls: Pregnancy and Family Planning in Multiple Sclerosis, pt. 3

Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the third of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by Dr. Langer-Gould in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.
undefined
Jul 9, 2019 • 2min

Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
undefined
Jul 8, 2019 • 1min

First Cannabis-Derived Pharmaceutical

Dr. Jerzy Szaflarski talks about the FDA's approval of the first cannabis-derived pharmaceutical for the treatment of epilepsy and Lennox-Gastaut syndrome in particular. For more, read the full article, "The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?" by Dr. Szaflarski in JAMA Neurology: https://jamanetwork.com/journals/jamaneurology/article-abstract/2714720.
undefined
Jul 5, 2019 • 2min

Sports Concussion Conference 2019

Co-director Dr. Brian Hainline talks about new features and highlights of the 2019 AAN Sports Concussion Conference. The conference takes place July 26-28 in Indianapolis.
undefined
Jul 4, 2019 • 2min

Continuum Pearls: Pregnancy and Family Planning in MS, pt. 2

Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the second part of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by Dr. Langer-Gould in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app